Birgit Thierry-Carstensen

886 total citations
15 papers, 655 citations indexed

About

Birgit Thierry-Carstensen is a scholar working on Infectious Diseases, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Birgit Thierry-Carstensen has authored 15 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 8 papers in Epidemiology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Birgit Thierry-Carstensen's work include Viral gastroenteritis research and epidemiology (5 papers), Viral Infections and Immunology Research (5 papers) and Tuberculosis Research and Epidemiology (5 papers). Birgit Thierry-Carstensen is often cited by papers focused on Viral gastroenteritis research and epidemiology (5 papers), Viral Infections and Immunology Research (5 papers) and Tuberculosis Research and Epidemiology (5 papers). Birgit Thierry-Carstensen collaborates with scholars based in Denmark, United States and Netherlands. Birgit Thierry-Carstensen's co-authors include Peter Andersen, Ingrid Kromann, D. J. Lewis, Rino Rappuoli, Zhiming Huo, Giuseppe Del Giudice, Rafaela Giemza, Susan W. Barnett, Eva Galiza and Deborah L. Novicki and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and The Lancet Infectious Diseases.

In The Last Decade

Birgit Thierry-Carstensen

15 papers receiving 637 citations

Peers

Birgit Thierry-Carstensen

IMMUN

EPIDE

MICRO

Rafaela Giemza United Kingdom

Henrik Aggerbeck Denmark

Ross W. Ward Ireland

Stéphanie Longet United Kingdom

Ilse De Coster Belgium

Wayne Russell United Kingdom

Nguyen Than Ha Quyen Vietnam

Charlotta Bergquist Sweden

Waldely O. Dias Brazil

G.J.M. van Scharrenburg Netherlands

Rafaela Giemza United Kingdom

Birgit Thierry-Carstensen

216 ×0.7

242 ×0.8

IMMUN

161 ×0.6

EPIDE

56 ×0.4

MICRO

87 ×0.8

Citations per year, relative to Birgit Thierry-Carstensen Birgit Thierry-Carstensen (= 1×) peers Rafaela Giemza

Countries citing papers authored by Birgit Thierry-Carstensen

Since Specialization

Citations

This map shows the geographic impact of Birgit Thierry-Carstensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Thierry-Carstensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Thierry-Carstensen more than expected).

Fields of papers citing papers by Birgit Thierry-Carstensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Thierry-Carstensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Thierry-Carstensen. The network helps show where Birgit Thierry-Carstensen may publish in the future.

Co-authorship network of co-authors of Birgit Thierry-Carstensen

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Thierry-Carstensen. A scholar is included among the top collaborators of Birgit Thierry-Carstensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Thierry-Carstensen. Birgit Thierry-Carstensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Sáez‐Llorens, Xavier, et al.. (2020). Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, following vaccination in children at 2, 4, 6 and at 15–18 months. Vaccine. 38(21). 3780–3789. 8 indexed citations

Bravo, Lulu, Josefina Carlos, Salvacion Gatchalian, et al.. (2019). Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: A phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14 weeks and 9 months of age. Vaccine. 38(3). 530–538. 10 indexed citations

Rivera, Luis, Rasmus S. Pedersen, Lars Vibe Andreasen, et al.. (2017). Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial. The Lancet Infectious Diseases. 17(7). 745–753. 9 indexed citations

Tingskov, Pernille N., Bettina S. Nedergaard, Lars Vibe Andreasen, et al.. (2016). First-in-human safety and immunogenicity investigations of three adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when given as a booster vaccination to adolescents with a history of IPV vaccination at 3, 5, 12 months and 5 years of age. Vaccine. 35(4). 596–604. 5 indexed citations

Dissel, Jaap T. van, Simone A. Joosten, Søren T. Hoff, et al.. (2014). A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human. Vaccine. 32(52). 7098–7107. 190 indexed citations

Dissel, Jaap van, Simone A. Joosten, Andrew J. Graves, et al.. (2014). Vaccination with a Hybrid 1 (H1) fusion protein combined with a liposomal adjuvant (CAF01) induced antigen specific T-cells 3 years post vaccination in a human clinical trial. (VAC7P.971). The Journal of Immunology. 192(Supplement_1). 141.16–141.16. 9 indexed citations

Thierry-Carstensen, Birgit, et al.. (2013). Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults—A review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience. Vaccine. 31(45). 5178–5191. 53 indexed citations

Thierry-Carstensen, Birgit, et al.. (2012). A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults. Vaccine. 30(37). 5464–5471. 31 indexed citations

Tingskov, Pernille N., Birgit Thierry-Carstensen, Søren T. Hoff, et al.. (2010). First-in-Man Open Clinical Trial of a Combined rdESAT-6 and rCFP-10 Tuberculosis Specific Skin Test Reagent. PLoS ONE. 5(6). e11277–e11277. 29 indexed citations

10.

Lewis, D. J., Zhiming Huo, Susan W. Barnett, et al.. (2009). Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin. PLoS ONE. 4(9). e6999–e6999. 237 indexed citations

11.

Lillebæk, Troels, Pernille N. Tingskov, Birgit Thierry-Carstensen, et al.. (2009). Risk of sensitization in healthy adults following repeated administration of rdESAT-6 skin test reagent by the Mantoux injection technique. Tuberculosis. 89(2). 158–162. 11 indexed citations

12.

Pietrzyk, Jacek J, Jacek Wysocki, Andrzej Gałaj, et al.. (2008). Safety and immunogenicity of a DTaP-IPVVero (serum-free) combination vaccine in comparison to DTaP-IPVMkc when administered simultaneously with Haemophilus influenzae type b conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age. Vaccine. 26(41). 5296–5303. 9 indexed citations

13.

Arend, Sandra M., Willeke P. J. Franken, Henrik Aggerbeck, et al.. (2008). Double-blind randomized Phase I study comparing rdESAT-6 to tuberculin as skin test reagent in the diagnosis of tuberculosis infection. Tuberculosis. 88(3). 249–261. 46 indexed citations

14.

Thierry-Carstensen, Birgit, Mikael Frederiksen, Peter Henrik Andersen, & Michael Stellfeld. (2004). Spontaneously reported adverse reactions after diphtheria–tetanus revaccination at 4–6 years of age—a comparison of two vaccines with different amounts of diphtheria toxoid. Vaccine. 23(5). 668–671. 2 indexed citations

15.

Haastrup, Eva, et al.. (2003). Safety and immunogenicity of a booster dose of inactivated poliovirus vaccine produced in vero-cells. Vaccine. 22(8). 958–962. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact